4//SEC Filing
HANTSON LUDWIG 4
Accession 0000899866-20-000097
CIK 0000899866other
Filed
Dec 17, 7:00 PM ET
Accepted
Dec 18, 5:12 PM ET
Size
8.0 KB
Accession
0000899866-20-000097
Insider Transaction Report
Form 4
HANTSON LUDWIG
DirectorCEO
Transactions
- Award
Common Stock, par value $.0001 per share
2020-12-16+162,707→ 353,365 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−13,059$2,062,800→ 267,773 total - Tax Payment
Common Stock, par value $.0001 per share
2020-12-16$157.96/sh−72,533$11,457,313→ 280,832 total
Footnotes (3)
- [F1]Shares acquired on vesting of Performance Stock Units previously granted on February 28, 2018 under the 2017 Stock Incentive Plan.
- [F2]This sale was made to cover withholding taxes immediately following the vesting of previously granted Performance Stock Units.
- [F3]This sale was made to cover withholding taxes immediately following the vesting of previously granted Restricted Stock Units.
Documents
Issuer
ALEXION PHARMACEUTICALS, INC.
CIK 0000899866
Entity typeother
Related Parties
1- filerCIK 0001491435
Filing Metadata
- Form type
- 4
- Filed
- Dec 17, 7:00 PM ET
- Accepted
- Dec 18, 5:12 PM ET
- Size
- 8.0 KB